IP Library Granted Patent US 11,573,235
Granted Patent B2
US 11,573,235 · App. 14/388,057 · Granted Feb 7, 2023

Methods for generating an image of a biological sample

Inventors: Antti E. Seppo (Niskayuna, NY); Fiona Ginty (Niskayuna, NY); Kevin B. Kenny (Niskayuna, NY); David Lavan Henderson (Niskayuna, NY); Michael J. Gerdes (Niskayuna, NY); Adriana Ines Larriera (Niskayuna, NY); Xiaofeng Liu (Niskayuna, NY); Alex D. Corwin (Niskayuna, NY); Stephen E. Zingelewicz (Niskayuna, NY); Thomas Ha (Aliso Viejo, CA); Natalia R. Jun (Aliso Viejo, CA); Ainura Kyshtoobayeva (Aliso Viejo, CA); Denise A. Hollman-Hewgley (Aliso Viejo, CA); Ying Li (Niskayuna, NY)
Assignee: LEICA MICROSYSTEMS CMS GMBH
G01N33/582C12Q1/6816C12Q1/6841G01N33/6803G06T7/0012G06V20/695G06T2207/10064G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,573,235
App. No.
14/388,057
Granted
Feb 7, 2023
Kind
B2
Abstract

A method for generating an image of a region of interest in a biological sample comprising the steps of: generating a first image including the region of interest of the biological sample having undergone a first protocol but not a second protocol; and generating a second image including the region of interest of the biological sample after having undergone a second protocol; wherein the region of interest is smaller than said sample. Also provided is a method of analyzing a biological sample, comprising providing an image of the biological sample according to the method for generating an image of a region of interest in a biological sample, and analyzing the biological sample from the image. Further provided are system and kit that comprise the means for executing the novel methods.

Claims (15)

1. A method of generating a composite image of a region of interest in a human tissue sample comprising the steps of:

1) generating a first image including said region of interest of said sample having undergone a first protocol but not a second protocol, wherein the first protocol comprises: (i) binding a human target protein-specific monoclonal antibody labeled with a fluorophore to the human target protein in the sample, wherein said human target protein is selected from the group consisting of EGFR, Her2, ALK, galactosyl transferase II, neuron specific enolase, proton ATPase-2, acid phosphatase, Ki67, cyclin E, p53 and cMet; (ii) detecting by immunofluorescence the bound fluorophore to generate the first image, and (iii) staining the sample with a fluorescent marker that provides morphological information, and;

2) digesting said sample with a protease after generating the first image but before said sample has undergone the second protocol;

3) generating a second image including said region of interest of said sample after having undergone the second protocol, wherein the second protocol comprises: (i) hybridizing a nucleic acid probe labeled with a fluorophore to a target nucleic acid in the sample, wherein the target nucleic acid encodes a selective portion of the human target protein; and (ii) detecting by immunofluorescence the hybridized probe fluorophore to generate the second image wherein the nucleic acid probe is a DNA or RNA of from 4 to 50 nucleotides; and

4) generating a composite image that includes at least the region of interest from each of the first and the second images by registering fluorescent signals from the first image with fluorescent signals from the second image and aligning and overlaying the first and second images based on the morphological information.

2. The method of claim 1 , wherein the region of interest is selected by comparing the first image of the tissue sample to pre-determined criterion.

3. The method of claim 1 , wherein the first protocol further includes immunofluorescence detection of at least one additional protein wherein the additional protein provides the morphological information.

4. The method of claim 1 , wherein said hybridizing reaction is selected from the group consisting of FISH, IQ-FISH, in-situ PCR, rolling circle amplification and primed in situ labeling.

5. The method of claim 1 , wherein the second protocol comprises staining the sample with a fluorescent marker that provides morphological information.

6. The method of claim 5 , wherein said fluorescent marker stains the nucleus of a cell.

7. The method of claim 1 , wherein at least one of the first or the second protocol comprises detecting autofluorescence of the tissue sample.

8. The method of claim 1 , wherein the first and second images are fluorescent images.

9. The method of claim 8 , wherein generating the first image and/or generating the second image comprises generating a brightfield type image.

10. A method of analyzing a human tissue sample, comprising providing an image of the sample according to claim 1 , and analyzing protein expression and nucleic acids of the sample from the image.

11. The method of claim 1 , wherein said second image covers a smaller area of said sample compared to an area of said sample covered by said first image.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2021
From: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
To: LEICA MICROSYSTEMS CMS GMBH
Reel/Frame 056256/0015 →
CHANGE OF NAME Recorded Aug 31, 2020
From: GE HEALTHCARE BIO-SCIENCES CORP.
To: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Reel/Frame 053648/0854 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2016
From: CLARIENT DIAGNOSTIC SERVICES, INC.
To: GE HEALTHCARE BIO-SCIENCES CORP.
Reel/Frame 037567/0736 →
Continuity (2)
Provisional Application 61618282 · Mar 30, 2012
Related Publication 20150050650A1 · Feb 19, 2015